Zobrazeno 1 - 10
of 10
pro vyhledávání: '"David Hagerty"'
Autor:
Lester Del Rey, Eve Fisher, Hal Charles, David Hagerty, Tom Marcinko, Larry Tritten, Murray Leinster, Malcolm Jameson, Edgar Wallace, Hulbert Footner
For mystery readers, Michael Bracken brings us an original tale by Eve Fisher—“The Ghost of Eros” features art crime of a most creative sort. Barb Goffman's presents an action-packed tale by David Hagerty. “A Photo's Worth” features an actr
Autor:
Miriam B. Vos, Lara Dimick-Santos, Ruby Mehta, Stephanie O. Omokaro, Johannes Taminiau, Elmer Schabel, David E. Kleiner, Peter Szitanyi, Piotr Socha, Jeffrey B. Schwimmer, Stephanie Noviello, Debra G. Silberg, Richard Torstenson, Veronica Miller, Joel E. Lavine, Nathalie Adda, William Baldyga, Rajarshi Banerjee, Cynthia Behling, Sherif Boulos, Gary Burgess, Dania Calboli, Edgar Charles, Rose Christian, Claude Cohen-Bacrie, Doina Cosma-Roman, Claus-Peter Danzer, Ingrid Delaet, Mark Delegge, Nicholas DiProspero, Kathleen Donohue, Laurent Fischer, Emer Fitzpatrick, Michael Fried, David Hagerty, Paula Hale, Keri Hildick, Dean Hum, Khurram Jamil, Lijuan Jiang, Saul Karpen, Matt Kelly, Rohit Kohli, Kattayoun Kordy, Nancy Krieger, Joel Lavine, Lois Lee, Eric Lefebvre, Patricia Lopez, Erica Lyons, Laura Malahias, Sophie Megnien, Peter Mesenbrink, Pansy Minnick, Christine Murray, Tien Nghiem, Nikki Nicholson, Wenjie Pang, Lisa Percival, Dan Peres, Margaret Powell, Dragos Roman, Mark Root, Claire Sampson, Arun Sanyal, Kathleen Schwarz, Star Seyedkazemi, David Shapiro, Reshma Shringarpure, Debra Silberg, Edward Smith, Robert Squires, William Treem, Pamela Vig, Miriam Vos, Mason Yamashita, Michael Zemel
Publikováno v:
Gastroenterology
Autor:
Mark C. Genovese, T. Shaw, Matt Cravets, Edward C. Keystone, David Hagerty, Paul P. Tak, Paul Emery, Stanley Cohen, Charles Peterfy
Publikováno v:
Annals of the rheumatic diseases, 69(6), 1158-1161. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(6), 1158-1161. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 69(6), 1158-1161. BMJ Publishing Group
Annals of the Rheumatic Diseases
BackgroundRituximab inhibited structural damage at 1 year in patients with rheumatoid arthritis (RA) who had had a previous inadequate response to tumour necrosis factor (TNF) inhibitors.ObjectiveTo assess structural damage progression through 2 year
Autor:
Mark C. Genovese, Paul P. Tak, Edward C. Keystone, T. Shaw, Charles Peterfy, Sarah Williams, Tore K Kvien, Gerd R Burmester, Maria Greenwald, David Hagerty, Paul Emery, M. Cravets, Maxime Dougados, Stanley Cohen
Publikováno v:
Annals of the Rheumatic Diseases, 68(2), 216-221. BMJ Publishing Group
Annals of the rheumatic diseases, 68(2), 216-221. BMJ Publishing Group
Annals of the rheumatic diseases, 68(2), 216-221. BMJ Publishing Group
Objective:To determine if treatment with a B cell-targeted therapy can inhibit the progression of structural joint damage in patients with rheumatoid arthritis (RA), exhibiting an inadequate response to tumour necrosis factor (TNF) inhibitors.Methods
Autor:
David Hagerty, Maxime Dougados, Jane Box, Michael Schiff, Joel M. Kremer, Mark C. Genovese, Tracy Li, Yvonne Sherrer, Jean-Claude Becker, C. Birbara, Michael E. Luggen, Richard Aranda, Kannan Natarajan, Isaac Nuamah
Publikováno v:
New England Journal of Medicine. 353:1114-1123
A substantial number of patients with rheumatoid arthritis have an inadequate or unsustained response to tumor necrosis factor alpha (TNF-alpha) inhibitors. We conducted a randomized, double-blind, phase 3 trial to evaluate the efficacy and safety of
Autor:
Thomas C. Pearson, Norma S. Kenyon, Robert M. Townsend, Christian P. Larsen, Karen Price, Nozomu Shirasugi, Andrew B. Adams, Dianne Hollenbaugh, David Hagerty, Thomas R. Jones, Shannon R. Cowan, Elizabeth Strobert, Rose Hendrix, Megan M. Durham, Phyllis Rees
Publikováno v:
The Journal of Immunology. 174:542-550
In recent years, reagents have been developed that specifically target signals critical for effective T cell activation and function. Manipulation of the CD28/CD80/86 and CD40/CD154 pathways has exhibited extraordinary efficacy, particularly when the
Autor:
David Hagerty, Jean-Claude Becker, Eduardo Di Giorgio, Rieke Alten, Maxime Dougados, P. Emery, Anthony H. Russell, Larry W. Moreland, G Rhys Williams, Isaac Nuamah, Serge Steinfeld, Marc Leon, Rene Westhovens, Joel M. Kremer
Publikováno v:
New England Journal of Medicine. 349:1907-1915
Effective new therapies are needed for rheumatoid arthritis. Current therapies target the products of activated macrophages; however, T cells also have an important role in rheumatoid arthritis. A fusion protein--cytotoxic T-lymphocyte-associated ant
Autor:
Peter S. Linsley, Naemura Joseph R, Lori A. Turk, Elizabeth Strobert, Robert J. Peach, Shannon R. Cowan, Robert M. Townsend, Christian P. Larsen, David Hagerty, John Emswiler, Daniel G. Anderson, Paul L. Tso, Jo Anne L. Greene, Nozomu Shirasugi, Thomas C. Pearson, Jürgen Bajorath, Andrew B. Adams, Karen Price
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5(3)
Current success in organ transplantation is dependent upon the use of calcineurin-inhibitor-based immunosuppressive regimens. Unfortunately, current immunotherapy targets molecules with ubiquitous expression resulting in devastating non-immune side e
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Biomembranes. 858:47-55
The phosphatidylcholine content of both the intestinal and renal brush-border membranes and ion transport are affected by 1,25-dihydroxycholecalciferol (1,25(OH)2D3). To investigate the mechanism of this effect, liposomes were prepared containing sel
Publikováno v:
Journal of Chemical Education. 61:550
Polymer chemistry is becoming an increasingly important aspect of industrial and synthetic chemical processes. Yet many undergraduate chemistry curricula provide little exposure to polymeric reagents and their diverse applications for organic synthes